Proapoptotic Bcl-2 family members alter mitochondrial permeability resulting in the release of apoptogenic factors that initiate a caspase cascade. These changes are well described; however, the effects of caspases on mitochondrial function are less well characterized. Here we describe the consequence of caspase-9 and effector caspase inhibition on mitochondrial physiology during intrinsic cell death. Caspase inhibition prevents the complete loss of mitochondrial membrane potential without affecting cytochrome c release. When effector caspases are inhibited, mitochondria become uncoupled and produce reactive oxygen species. Interestingly, the effector caspase-mediated depolarization of the mitochondria occurs independent of the activity of complexes I-IV of the electron transport chain. In contrast, caspase-9 inhibition prevents mitochondrial uncoupling and ROS production and allows for continued electron transport despite the release of cytochrome c. Taken together, these data suggest that activated caspase-9 prevents the accessibility of cytochrome c to complex III, resulting in the production of reactive oxygen species, and that effector caspases may depolarize mitochondria to terminate ROS production and preserve an apoptotic phenotype.
Introduction
Apoptosis is the genetically encoded process of cell suicide that maintains cellular and tissue homeostasis. Growth factor withdrawal and genotoxic stress induce apoptosis through the intrinsic cell death pathway, while instructive cell death occurs through the extrinsic pathway. Distinct families of proteins regulate the initiation and execution of these pathways; among them are the Bcl-2 and the caspase families (Danial and Korsmeyer, 2004; Lowe et al., 2004) .
The Bcl-2 family consists of three subfamilies of proteins: the Bcl-2-like, the BH3-only and the Bax-like proteins (Gross et al., 1999a) . The BH3-only proteins function as sentinels that sense cellular stress and are often modified in response to DNA damage, growth factor withdrawal or death receptor ligation . The BH3-only proteins promote mitochondrial permeability through the inactivation of antiapoptotic Bcl-2 proteins (Bcl-2/Bcl-x L ), the activation of proapoptotic Bcl-2 proteins (Bax/Bak) or both Wei et al., 2001) . Activation of Bax and Bak results in the release of several factors from the mitochondria, including cytochrome c Wei et al., 2001) . Once in the cytosol, cytochrome c binds Apaf-1 and procaspase-9, forming the apoptosome, and allows for the activation of caspase-9 (Li et al., 1997 ). Caspase-9 can then directly cleave and activate effector caspases, such as caspase-3 and -7 (Li et al., 1997) .
Effector caspases are responsible for initiating the events that lead to the hallmarks of apoptosis, including DNA laddering and cellular morphological changes (Borner and Monney, 1999; Shi, 2002) . While the loss of the mitochondrial membrane potential (DC m ) is another characteristic of cell death, it remains controversial whether the loss of DC m results in, or is a consequence, of caspase activation. The loss of DC m could occur by opening of the permeability transition pore (PTP), a proteinacious pore that spans the inner and outer membranes of the mitochondria (Marzo et al., 1998a, b) . The PTP model suggests that the release of cytochrome c and the loss of DC m are coupled events. However, the release of cytochrome c can occur independent of mitochondrial depolarization, suggesting that cytochrome c release and the loss of DC m are distinct and independent events (Bossy-Wetzel et al., 1998; Kim et al., 2000) . Moreover, a primary component of the PTP, the adenine nucleotide transporter (ANT) is not required for induction of permeability transition and apoptosis (Kokiszka et al., 2004) .
Previously, we have shown that the release of cytochrome c and the loss of DC m are separate events . Bcl-x L does not inhibit TNFainduced caspase-3 activation, loss of DC m or apoptosis in FL5.12 cells. However, Bcl-x L retains its ability to prevent cytochrome c release . Taken together, these data suggest that the loss of DC m occurs independent of Bcl-x L function as well as cytochrome c release and may be mediated by effector caspases. Here, we report the effects of caspase inhibition on mitochondrial function, following the release of cytochrome c. Inhibition of caspase activity during an intrinsic death signal results in a failure of mitochondria to completely depolarize despite cytochrome c redistribution. Inhibition of caspase-9 prevents mitochondrial uncoupling and increased reactive oxygen species (ROS) production. Interestingly, when effector caspases are inhibited, mitochondria are uncoupled and show increased production of ROS. These effects occur without affecting the function of complexes I, II, III and IV of the electron transport chain (ETC). Taken together, these data suggest that caspase-9 and effector caspases have sequential and distinct effects on mitochondrial physiology during apoptosis.
Results
Caspase inhibition blocks IL-3 withdrawal-induced death FL5.12 cells are a nontransformed pro-B cell line dependent on interleukin-3 (IL-3) for their growth and survival (Vander Heiden et al., 2001) . Vector control FL5.12 cells (Neo) die rapidly following IL-3 withdrawal and overexpression of Bcl-x L, or the addition of 100 mM of the pan-caspase inhibitor BocD-fmk (BocDtreated) can inhibit IL-3 withdrawal-induced apoptosis ( Figure 1a ). Growth factor withdrawal is an intrinsic cell death where cytochrome c release is required for caspase Figure 1 Caspase inhibition blocks IL-3 withdrawal-induced mitochondrial depolarization. (a) FL5.12 Neo (7100 mM BocD-fmk) and Bcl-x L cells were withdrawn from IL-3 and viability was assessed by propidium iodide exclusion at 12, 16 and 20 h by flow cytometry. The data represent the mean and s.d. of three or more experiments. (b) FL5.12 Neo (7BocD-fmk) and Bcl-x L cells were cultured in the presence ( þ IL-3) or in the absence of IL-3 (ÀIL-3) for 20 h. Cells were fixed, permeabilized, stained for cytochrome c and subjected to confocal imaging. The micrographs are representative of three independent experiments. (c) FL5.12 Neo and Bcl-x L cells were treated as in a and stained with 150 nM TMRE to assay DC m at 12, 16, and 20 h by flow cytometry. The data are representative of three or more independent experiments Caspases alter mitochondrial function E Cepero et al activation (Vander Heiden et al., 1997; Danial and Korsmeyer, 2004) . To ensure that BocD was functioning downstream of cytochrome c release, confocal imaging of cytochrome c, following growth factor withdrawal, was performed (Figure 1b ). In the presence of IL-3, cytochrome c displays a punctate and perinuclear pattern of staining, indicative of mitochondrial localization. When Neo cells are withdrawn from IL-3, cytochrome c redistributes from punctate and perinuclear to a diffuse cytoplasmic staining pattern, both in the presence and absence of BocD. In contrast, Bcl-x L cells retain punctate and perinuclear staining in the absence of IL-3 (Figure 1b ). These data indicate that during IL-3 withdrawal-induced apoptosis, Bcl-x L inhibits the death signal upstream of cytochrome c release, whereas BocD inhibits downstream of cytochrome c release.
Since BocD is sufficient to prevent cell death without affecting cytochrome c release, the effects of caspase inhibition on the DC m were determined. FL5. Figure 1c) . Additionally, the DC m int population was observed in both FL5.12 and Jurkat cells when treated with etoposide, taxol or staurosporine in the presence of BocD (Figure 2 and Tables 1-3) . Interestingly, the transition out of the DC m hi state is unaffected by BocD, as the same number of cells exit the DC m hi state in the presence and absence of BocD (Figure 1c ). To assure that these effects were not due to nonspecific effects of fluoromethylketone-based inhibitors, we determined the 
BocD results in increased ROS production
Cytochrome c is part of the electron transport chain and shuttles electrons from complex III-IV; therefore, the loss of cytochrome c may result in an inhibition of electron flow at complex III (Saraste, 1999) . Since complex III is a site of ROS production (Raha and Robinson, 2001) , we determined whether the maintenance of a DC m int affects ROS production. FL5.12 and Jurkat cells were simultaneously assayed for DC m (TMRE) and H 2 O 2 production (H 2 DCFDA) by FACS (Figure 2 ). In the presence of IL-3, FL5.12 Neo cells maintain a high membrane potential and the normal ROS production associated with electron transport (DC m hi /ROS þ ) ( Figure 2a and (Figure 2b  and Table 2 ). To assure that these changes are not specific to FL5.12 cells, Jurkat cells were treated with etoposide, taxol and staurosporine in the presence and absence of BocD ( Figure 2c and Table 3 Figure 2c and Table 3 ). Thus, the BocD-maintained DC m int /ROS hi state is specific neither to the death stimulus nor to the cell type and may be a general characteristic of the intrinsic cell death pathway. Consistent with previous findings, both FL5.12 and Jurkat Bcl-x L cells undergo a slight decrease in their DC m and ROS production, suggesting that Bcl-x L allows cells to enter into a quiescent state following an intrinsic apoptotic insult ( Figure 2 and Tables 1 and 2 ) (Vander Heiden et al., 1997 Rathmell et al., 2000) . These data indicate that caspase inhibition with BocD prevents the complete loss of DC m and that mitochondria with an intermediate potential generate more ROS.
The caspase-independent transition from the DC m hi to the DC m int state correlates with cytochrome c redistribution While the transition from the DC m int to the DC m low state is caspase dependent, the transition from the DC m hi to the DC m int state is caspase independent, as BocD does not affect this transition (Figure 1c ). Since the release of the cytochrome c is a caspase-independent event (Goldstein et al., 2000) , we reasoned that the exit out of the DC m hi is likely due to the loss of cytochrome c. Due to technical difficulties in sorting drug-treated cells, we generated a caspase-9 dominant negative that would allow us to sort and analyse a large number of cells by FACS. Mutating the murine caspase-9 catalytic cysteine to a serine (C325S) generates a dominant negative protein that was overexpressed in FL5.12 cells (C9DN cells, Figure 4b ) (Fearnhead et al., 1997) . The C9DN cells are resistant to IL-3 withdrawal-induced apoptosis and protection is downstream of cytochrome c release, as in BocD-treated Neo cells (Figure 3a and b) . When withdrawn from IL-3, C9DN cells maintain a DC m int , in a similar fashion to the IL-3-withdrawn BocD-treated Neo cells (Figure 3c) .
In order to determine if the transition from the DC m hi to the DC m int state correlates with the release of cytochrome c, C9DN cells were withdrawn from IL-3 for 48 h. The DC m hi and DC m int populations were sorted by FACS (>98% purity) and stained for cytochrome c localization. As seen in Figure 3d , the DC m hi cells have a punctate and perinuclear staining pattern indicative of mitochondrial localization, whereas the DC m int cells show a diffuse cytosolic staining. These data are consistent with the possibility that cytochrome c redistribution causes the transition from the DC m hi to the DC m int state.
Caspase-9 inhibition prevents ROS production
Since the caspase-9 dominant negative prevents caspase activation downstream of cytochrome c release and maintains mitochondria with a DC m int , we were surprised to find that these cells failed to increase ROS when withdrawn from IL-3 (Figure 3e and Tables 1 and 2 ). In the presence of IL-3, FL5.12 cells maintain comparable levels of ROS (Figures 2a and 3d) (Figure 2 and Table 1 ). However, IL-3-withdrawn and etoposide-treated C9DN cells transition to an intermediate potential and the cells produce ROS although at a lower level than cells grown in the presence of IL-3 or in the absence of IL-3 plus BocD (referred to as the DC m int /ROS þ state, Figure 3e and Tables 1 and 2 ). These effects of the C9DN do not appear to be related to overexpression of a CARD protein as overexpression of an inactive form of the CARD-containing caspase-12 has no effect on DC m or ROS production (LHB, unpublished observation). Thus, inhibition of caspase-9 suppresses ROS production, while BocD augments it. Therefore, either BocD affects some other cellular process that results in ROS production or both work at distinct steps in a linear death pathway. In order to distinguish between these two possibilities, C9DN cells were withdrawn from IL-3 in the presence of BocD. As seen in Figure 3e and Table 1 , the presence of BocD does not increase ROS production in IL-3-withdrawn C9DN cells.
BocD is more effective at inhibiting effector caspases than caspase-9
The inability of BocD to cause ROS production in IL-3-withdrawn C9DN cells suggests that BocD is inhibiting cell death downstream of caspase-9. In order to ensure that BocD was effectively inhibiting caspase activity, we assayed for a caspase-dependent event, that is, intranucleosomal DNA degradation (Shi, 2002) . Genomic DNA was isolated from Neo (7BocD), Bcl-x L and C9DN cells in the presence and absence of IL-3. Neo cells, withdrawn from IL-3, display a classical DNA ladder (Figure 4a ). In contrast, BocD, Bcl-x L and the caspase-9 dominant negative inhibit DNA fragmentation, indicative of inhibition of effector caspases (Figure 4a) . Therefore, the effects of BocD on the processing and activation of caspase-9 and caspase-3 were determined. IL-3-withdrawn Neo, Bcl-x L and C9DN cells were analysed by Western blot for the loss of procaspase-9 and the caspase-9-dependent cleavage of caspase-3. As seen in Figure 4b , procaspase-9 is processed and its cleavage fragment (p35) is detected in IL-3-withdrawn Neo cells. Surprisingly, IL-3-withdrawn BocD-treated Neo cells also contain cleaved caspase-9 and reduced procaspase-9, suggesting that BocD does not inhibit the auto-processing of procaspase-9. Additionally, IL-3-withdrawn Neo cells display a loss of procaspase-3, in the presence and absence of BocD, indicating that caspase-9 is active in the presence of BocD (Figure 4c ). In contrast, there is no detectable loss of procaspase-9 or procaspase-3 in either IL-3-withdrawn Bcl-x L or C9DN cells (Figure 4b and c) . Interestingly, we consistently find more caspase-9 processing and activity in the presence of BocD than in its absence, suggesting that effector caspases may be affecting caspase-9 function (Figure 4b and c) . Consistent with this observation, caspase-3 has been shown to feedback on the apoptosome (Bratton et al., 2001) .
Since BocD-fmk can inhibit DNA laddering but does not inhibit caspase-9 or caspase-3 processing, we hypothesized that BocD-fmk was selectively inhibiting caspase-3 activity. Therefore, we determined the effects of caspase inhibition on the intracellular DEVDase activity of IL-3-withdrawn cells. Cells were deprived of IL-3 for 24 h and incubated with the cell-permeable caspase-3-like substrate PhiPhiLux-G 1 D 2 . In the presence of IL-3, there is no DEVDase activity, whereas 7372.1% of IL-3-withdrawn Neo cells are positive for Caspases alter mitochondrial function E Cepero et al DEVDase activity (Figure 4d ). In contrast, BocDtreated Neo, Bcl-x L and C9DN cells display no significant increase in effector caspase activity upon IL-3 withdrawal. Moreover, when caspase activity was monitored with a cell permeable caspase-9 substrate, BocD-fmk had no effect, while C9DN completely blocked caspase-9 activity (Figure 4e ). Taken together, these data suggest that BocD selectively inhibits effector caspases, whereas the caspase-9 dominant negative is inhibiting at the level of caspase-9 during IL-3 withdrawal in FL5.12 cells.
Caspases do not affect complexes I-IV of the electron transport chain
One potential mechanism that effector caspases may employ to cause a loss of the DC m is by inactivating the enzymes that generate the mitochondrial membrane potential. Therefore, we determined whether complexes I-IV are functional in the presence of full caspase activity. FL5.12 Neo, Bcl-x L and C9DN cells incubated in the presence and absence of IL-3 for 24 h were freezethawed to disrupt the inner mitochondrial membrane. The function of complexes I þ III and II þ III was assayed by the ability of NADH and succinate, respectively, to reduce oxidized cytochrome c ( Figure  5a and b) (Barrientos et al., 1998) . Both NADH and succinate are able to reduce cytochrome c in IL-3-withdrawn cell lysates, suggesting that complexes I-III are functional in the presence of caspase activity. Similarly, the ability of complex IV to oxidize reduced cytochrome c was assayed in IL-3-withdrawn cell lysates (Figure 5c ). Similar to the other complexes, complex IV was equally functional in the presence and absence of IL-3 in all cell lines. Taken together, these data suggest that caspases do not inactivate complexes I-IV of the electron transport chain directly.
Effects of caspase inhibition on mitochondria
Inhibition of caspase activity during IL-3 withdrawalinduced apoptosis results in the maintenance of a DC m int population; however, effector caspase inhibition results in increased ROS production, while caspase-9 inhibition prevents the generation of ROS (Table 1) . Mitochondria normally produce ROS due to the loss of electrons from the ETC to oxygen (Cai and Jones, 1998; Raha and Robinson, 2001 ). Inefficiency in electron transport from complexes I/II to complex III or pharmacologic inhibition of complex III results in increased ROS production. Since complex III is the major ROS-generating enzyme complex of the ETC, we reasoned that, in the absence of effector caspase activity, mitochondria continue shuttling electrons that are lost to oxygen due to the redistribution of cytochrome c. Thus, one potential explanation for the difference in ROS production between BocD-treated Neo and C9DN cells is in their ability to perform and complete electron transport. Antimycin A is a complex III inhibitor that prevents complex III from accepting electrons from the quinone pool (Raha and Robinson, 2001 ). Antimycin A causes increased ROS due to the loss of electrons at the quinone pool. Consistent with these findings, in the presence of IL-3, all three cell lines display an increase in ROS production when treated with antimycin A (Figure 6a ). In the absence of IL-3, the majority of Neo cells are ROS À and they do not respond to antimycin A, suggesting that these cells are no longer capable of electron transport (Figure 6a ). In contrast, IL-3-withdrawn Bcl-x L and C9DN cells increase ROS production in response to antimycin A; therefore, the electron transport chain is intact despite the release of cytochrome c in the C9DN cells (Figures 3b and 6a) . However, IL-3-withdrawn BocD-treated Neo cells decrease ROS production in response to antimycin A (Figure 6a ). This suggests that the ROS produced in these cells is due to the loss of electrons between complex III and IV and not at the quinone pool and that these cells cannot complete electron transport. Since the DC m is generated by electron transport, we sought to determine how IL-3-withdrawn BocD-treated Neo cells were maintaining a potential in the absence of complete electron transport. Cells depleted of mitochondrial DNA (r 0 cells) lack a functional electron transport chain but are capable of maintaining a DC m by exchanging glycolytic ATP for ADP generated by the F 1 -ATPase (Chandel and Schumacker, 1999) . Oligomycin, an inhibitor of the F 1 F 0 -ATPase, can distinguish between mitochondria that are conducting coupled electron transport and uncoupled mitochondria (Rego et al., 2001) . Oligomycin causes an increased DC m in coupled mitochondria and a loss of DC m in uncoupled mitochondria. In Figure 6b , Neo (7BocD), Bcl-x L and C9DN cells in the presence and absence of IL-3 were treated with oligomycin (5 mg/ml for 60 min) and stained with TMRE prior to FACS analysis. In the presence of IL-3, oligomycin causes an increase in DC m (Figure 6b ). In contrast, oligomycin diminishes the DC m int population of BocD-treated Neo cells and there is a proportional increase in DC m low cells, whereas addition of FCCP collapsed the DC m in both untreated and oligomycin-treated cells (data not shown). These data suggest that the BocD-maintained DC m int mitochondria are operating the F 1 F 0 -ATPase in reverse and that the C9DN-maintained DC m int is a result of coupled electron transport.
Discussion
While the effects of proapoptotic Bcl-2 family members on mitochondrial function is an area of intense research, the ability of caspases to induce mitochondrial permeability is less understood. When incubated with recombinant caspases, isolated mitochondria undergo a Bcl-x L -inhibitable permeability transition, resulting in cytochrome c release and loss of DC m (Marzo et al., 1998a, b) . However, only during the extrinsic cell death pathway are effector caspases activated prior to mitochondrial permeability (Nagata, 1997; Johnson et al., 2000) . Additionally, several reports suggest that mitochondrial depolarization is independent of cytochrome c release and Bcl-x L function (Bossy-Wetzel et al., 1998; Gross et al., 1999b; Johnson et al., 2000; Kim et al., 2000) .
We used IL-3 withdrawal-induced apoptosis as a model of an intrinsic cell death to assess the effects of caspase inhibition on mitochondrial function, following cytochrome c release. The ability of BocD and C9DN to prevent the transition to a DC m low state is consistent with the lack of mitochondrial depolarization seen in Apaf-1-and caspase-9-deficient cells following an intrinsic death signal and in cell free assays of tBid-induced cytochrome c release Yoshida et al., 1998; Kim et al., 2000; Shimizu and Tsujimoto, 2000; von Ahsen et al., 2000) . Additionally, in the presence of caspase inhibitors several cell lines have been shown to undergo cytochrome c release, without a loss of DC m (BossyWetzel et al., 1998; Deshmukh et al., 2000; Goldstein et al., 2000; Waterhouse et al., 2001) . Taken together, these data suggest that mitochondria are targets of the caspase cascade. Interestingly, caspase inhibition does not affect the exit out of the DC m hi state, suggesting that this transition is caspase independent and that the transition to the DC m low state is caspase dependent. The ability of TMRE to measure the plasma membrane potential may explain the transition from a DC m hi to a DC m int state. However, the contribution of the plasma membrane potential to the overall fluorescence of FL5.12 cells, using 150 nM TMRE, is minimal, as determined by plasma membrane depolarization (unpublished observation). Since DC m hi cells contain all of the cytochrome c within the mitochondria and DC m int do not, we believe that the exit out of the DC m hi state is in part related to the caspase-independent release of cytochrome c.
Both BocD and C9DN prevent effector caspase activation and loss of DC m ; however, BocD-mediated caspase inhibition occurs at the level of effector caspases (Figure 4) . It is not clear why BocD can preferentially inhibit effector caspases, but selectivity among pancaspase inhibitors has been demonstrated before, as there is a greater than 10-fold difference in the K i s of zVAD-fmk for caspase-8 and caspase-3 (Garcia-Calvo et al., 1998). Additionally, crmA and p35, viral caspase inhibitors capable of caspase-9 inhibition in vitro, fail to do so in vivo (Ryan et al., 2002) . In contrast, the caspase-9 dominant negative is directly inhibiting caspase-9, since processing of procaspase-3 does not occur and DEVDase activity is undetected, suggesting that caspase-7 is also inhibited. The ability to inhibit caspase activity at distinct steps in the intrinsic cell death pathway allowed us to determine the effects of caspase-9 and effector caspases on mitochondrial physiology following cytochrome c release.
The DC m is generated by the translocation of protons from the mitochondrial matrix to the intermembrane space by complexes I, III and IV of the ETC (Saraste, 1999) . The proton gradient is used for a multitude of processes that mediate mitochondrial function. These include the generation of ATP by the F 1 F 0 -ATPase (coupled electron transport), the import of NADH and succinate by the shuttles on the inner mitochondrial membrane, protein import and ion homeostasis (Saraste, 1999) . The loss of electrons from the ETC to oxygen occurs mainly at complex III and results in the generation of superoxide and hydrogen peroxide. In the presence of effector caspase inhibition, mitochondria maintain a potential that may be used for the import of substrates for complexes I and II. Therefore, if complexes I-III continue functioning once cytochrome c has been released, electrons may be lost to oxygen between complexes III and IV, resulting in ROS. Consistent with this view, a report suggests that loss of cytochrome c results in ROS production and may explain why IL-3-withdrawn BocD-treated Neo cells increase ROS production (Cai and Jones, 1998) . Further supporting this hypothesis is the ability of antimycin A to diminish ROS production in IL-3-withdrawn BocDtreated Neo cells (Figure 6a ), as electron transport through complex III is abrogated. We believe these observations are common to the intrinsic cell death pathway, as the DC m int /ROS hi population is observed, regardless of death stimulus or cell type. Additionally, the transient maintenance of DC m following cytochrome c release is due to F 1 F 0 -ATPase reversal where the F 1 -ATPase hydrolyses ATP to generate a potential (Rego et al., 2001) . Consistent with this observation, the BocD-maintained DC m int population is diminished upon treatment with oligomycin ( Figure 6b ). Our data suggest that during IL-3 withdrawal-induced apoptosis mitochondria release cytochrome c and activate caspase-9. If effector caspases are inhibited, then the F 1 F 0 -ATPase is capable of maintaining a potential that allows the continued import of ETC substrates, uncoupled electron transport and the loss of electrons between complexes III and IV, resulting in ROS production. Whether effector caspases cause the loss of DC m by inactivating the F 1 F 0 -ATPase, by terminating mitochondrial substrate import or by some other undefined mechanism remains to be determined.
The ability of effector caspases to terminate mitochondrial function suggests that ROS production, in a dead or dying cell, is unfavorable. While ROS has been implicated in the initiation and execution of some cell deaths, excess ROS may change an apoptotic cell death to a necrotic cell death (Higuchi et al., 1998; Samali et al., 1999; Chandra et al., 2000; Burlacu et al., 2001; Higuchi and Yoshimoto, 2002) . Therefore, effector caspases may terminate ROS production to preserve the apoptotic phenotype in vivo and avert an inflammatory response. A recent report suggests that ROS is inhibited in the presence of zVAD-fmk; however, the authors did not show which caspases were inhibited by zVAD-fmk (Ricci et al., 2003) . If zVAD-fmk was inhibiting caspase-9, then these data are in agreement with our findings.
In contrast to effector caspase inhibition, caspase-9 inhibition prevents ROS and allows for coupled electron transport to occur despite the release of cytochrome c. If the loss of cytochrome c is the cause of ROS production, then these data suggest that caspase-9 affects the ability of cytochrome c to participate in electron transport. Consistent with these data, release of cytochrome c has been shown to be a reversible event, in the absence of caspase activity (Martinou et al., 1999; Mootha et al., 2001) . Additionally, in the presence of a caspase inhibitor following cytochrome c release, HeLa cells undergo a transient loss of DC m , which is restored by the passive diffusion of cytosolic cytochrome c back into the intermembrane space, thus maintaining coupled mitochondrial function (Waterhouse et al., 2001) .
The ability of cytochrome c to re-enter the intermembrane space may explain the paradox in ROS production between IL-3-withdrawn BocD-treated Neo and C9DN cells where, in the presence of caspase-9 activity (BocD-treated Neo cells), cytochrome c participation in electron transport is abrogated. This suggests that caspase-9 is preventing the re-entry of cytochrome c or the ability of cytochrome c to function in electron transport. Inactivation of cytochrome c by caspase-9 is an attractive idea; however, recombinant caspase-9 failed to cleave purified cytochrome c in vitro (data not shown). Recently, a caspase-sensitive cytosolic factor termed permeability-enhancing factor (PEF) that facilitates the diffusion of cytochrome c between the cytosol and the intermembrane space was characterized (Kluck et al., 1999) . Caspase-9-mediated inactivation of PEF could result in the inability of cytochrome c to efficiently re-enter the mitochondria, causing an inhibition of electron transport at complex III and ROS production.
Alternatively, caspase-9 could mediate a restructuring of the mitochondria that would result in the inability of cytochrome c to shuttle electrons. Recently, tBid has been shown to cause a reorganization of mitochondrial cristae that is required for the complete loss of cytochrome c in a BH3-independent fashion (Scorrano et al., 2002) . However, the involvement of tBid in the intrinsic cell death pathway is not well established. While caspase-8 initiates the extrinsic cell death pathway, caspase-9 is the initiator caspase of the intrinsic cell death pathway and could generate a tBid-like protein capable of the BH3-independent reorganization of the cristae. Since coupled respiration occurs primarily within the folds of the cristae, gross mitochondrial reorganization could ablate electron transport and result in ROS production (Scorrano et al., 2002) .
While the mechanism caspase-9 and effector caspases employ to inactivate mitochondria is unknown, our data suggest that complexes I-IV of the ETC are not the targets, as they are functional in the presence of both caspase-9 and effector caspases. In contrast, recent reports suggest that caspase-3 renders complex I and II nonfunctional (Ricci et al., 2003; Ricci et al., 2004) . This difference may be explained by the ability of substrates to cross the inner mitochondrial membrane (Saraste, 1999) . In our assay, the inner mitochondrial membrane was physically disrupted, allowing NADH and succinate direct access to complexes I and II, respectively. Ricci et al. (2003) measured oxygen comsumption driven by malate/palmitate (complex I) and succinate (complex II) in mitochondria incubated with caspase-3 and either tBid or digitonin. However, the authors have shown that caspase-3 can cleave substrates in Complex I (Ricci et al., 2004) . It remains to be determined if the differences in complex I activity observed in these studies are due to differences in the cell tested or the methods utilized to measure activity. Regardless, our data suggest that caspase-9 and effector caspases have differential and sequential effects on mitochondria. Thus, inactivation of complexes I and II could decrease electron transport to complex III and decrease ROS. Thus, the models may not be mutually exclusive. Whether caspase-9 directly cleave substrates on the mitochondria or whether they cleave secondary factors that affect the mitochondrial membrane potential remains to be determined.
Materials and methods

Cell culture
The IL-3-dependent murine pro-B cell line FL5.12 was cultured and transfected as previously described . All experiments were preformed using bulktransfected Neo, Bcl-x L and C9DN cells. The human T-cell line Jurkat was cultured in IMDM (Mediatech) supplemented with 10% FBS (Life Technologies), 2 mM L-glutamine, 100 U/ ml pen-strep, and 20 mM HEPES (Life Technologies). Jurkat cells were electroporated with pcDNA3.1 Bcl-x L and selected with 1 mg/ml G418. High-expressing single cell clones were used. BocD-fmk (BocD) ZFF-fmk and LLY-fmk were purchased from MP Biomedicals and used at a concentration of 100 mM.
Cell death induction and analysis
For IL-3 withdrawal-induced apoptosis, FL5.12 cells were washed three times in unsupplemented RPMI medium and resuspended at 5 Â 10 5 /ml in FL5.12 medium, without WEHI 3B supernatant, for the indicated times. For drug-induced apoptosis, Jurkat cells were seeded at 5 Â 10 5 /ml in complete medium and treated with 10 mg/ml etoposide, 500 nM taxol and 100 nM staurosporine for the indicated time points. All drugs were purchased from Sigma. Cell death was assayed by propidium iodide exclusion (2 mg/ml) and analysed on a FACScan flow cytometer (Becton Dickinson). The PhiPhiLux-G 1 D 2 and Caspalux9 (OncoImmunin) caspase activity assays were performed as previously described .
Confocal microscopy
FL5.12 Neo, Bcl-x L and C9DN cells were stained and analysed by confocal microscopy (Zeiss). Briefly, FL5.12 cells were washed twice with PBS, fixed with 4% paraformaldehyde (15 min at room temperature) and permeabilized with 0.1% Triton X-100 (5 min at room temperature). Cells were stained with an unlabeled anti-cytochrome c monoclonal antibody (45 min at 41C; 6H2.B4; Pharmingen) and detected with an anti-mouse IgG conjugated to FITC (45 min at 41C; Cappel).
Mitochondrial assays
The mitochondrial membrane potential was assayed, as previously described , using 150 and 100 nM TMRE (Molecular Probes, Inc.) for FL5.12 and Jurkat cells, respectively. H 2 O 2 production was assayed using 1 mM H 2 DCFDA (Molecular Probes, Inc.). Briefly, cells were incubated for 30 min with TMRE and/or H 2 DCFDA in Krebs-Ringer medium (127 mM NaCl, 5.5 mM KCl, 2 mM MgSO 2 , 2 mM CaCl 2 , 0.5 mM KH 2 PO 4 , 20 mM HEPES, pH 7.2, 10 mM glucose and 1% FBS), washed and resuspended in Krebs-Ringer medium supplemented with 15 nM TMRE. Samples were analyzed by flow cytometry on a FACScan. Cell populations of TMRE and H 2 DCFDA-stained cells were determined by drawing nonoverlapping gates on dot plots like those depicted in Figure 2 þ C9DN cells. Oligomycin (Calbiochem) was added at 5 mg/ml 1 h before FACS analysis and antimycin A (50 mg/ml; Sigma) was added 30 min prior to FACS analysis.
Chromosomal DNA isolation and fragmentation assay
Genomic DNA was isolated as previously described and 2 mg was run on a 1.5% agarose gel .
Western blotting
Western blotting was performed as previously described . The following primary antibodies were used: a mouse anti-caspase-3 monoclonal (clone 46, Pharmingen), a mouse anti-caspase-9 monoclonal (clone 5B4, MBL), and a rabbit anti-actin polyclonal (Sigma). The following secondary antibodies were used: a horseradish peroxidaseconjugated sheep anti-mouse Ig (Amersham) and a horseradish peroxidase-conjugated donkey anti-rabbit Ig (Amersham). Proteins were detected by enhanced chemiluminescence (Amersham).
Generation of the caspase-9 dominant negative
A murine caspase-9 cDNA clone lacking a start methionine was kindly provided by Yuri Lazebnik (CSHL, NY, USA). The start ATG was added by PCR and cloned into pBluescript and sequenced. The catalytic cysteine was mutated to a serine (C325S) with the QuickChange Site-Directed Mutagenesis kit (Stratagene). The product was cloned, sequenced, subcloned into pSFFVNeo and transfected into FL5.12 cells.
Electron transport chain complex assay
The function of complexes I þ III and II þ III was assayed as previously described on a Beckman DU-640 spectrophotometer (Barrientos et al., 1998) . Briefly, after 48 h in the presence or absence of IL-3, cells were freeze-thawed in PBScontaining 10% glycerol. Cell lysates (40-100 mg) were incubated at room temperature with 100 mM NADH (complex I þ III), 20 mM succinate (complex II þ III) or reduced cytochrome c (complex IV) in phosphate buffer (10 mM KH 2 PO 4 , 0.5 mM EDTA, pH 7.5). The reduction/oxidation of cytochrome c was measured as the increase/decrease in absorbance at 550 nm. Cytochrome c was reduced with sodium hydrosulfite. Complex IV was assayed in the presence of 2.5 mM lauryl maltoside and 10 mM antimycin A and complexes I þ III and II þ III were assayed in the presence of 2 mM KCN. Rotenone, TTFA, antimycin A and cyanide were used to determine specific activity. All chemicals were purchased from Sigma.
